Dr. Sarah Jayne Daywood, DNP, CRNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 404 Ridge St, Freeland, PA 18224 Phone: 570-825-8741 |
News Archive
Since its first outbreak in Guinea in December, 2013, Ebola has hit West African healthcare providers disproportionately hard.
Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients, at the 2015 annual meeting of the American Society for Clinical Oncology. This application expands the investigational utility of Epic Sciences' no cell left behind™ platform to characterize circulating tumor cell (CTC) genomic alterations.
Halozyme Therapeutics, Inc. today announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of a subcutaneous formulation of rivipansel, a compound discovered by GlycoMimetics, Inc. and being developed by Pfizer Inc., using Halozyme's ENHANZE formulation.
Aggressive forms of bladder cancer involve the protein PODXL - a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.
› Verified 1 days ago